Sign inJoin waitlistJoin the waitlist

Kelly Stratton

Associate Dean for Veteran's Affairs · University of Oklahoma College of Medicine

Credentials: · · · · ·

History

University of Oklahoma College of Medicine
Present
University of Oklahoma College of Medicine
Present
University of Oklahoma College of Medicine
Present

Urology
Vanderbilt University Medical Center
2014–2019
Pathology-Anatomic and Clinical
University of Oklahoma College of Medicine
2010–2014
Memorial Sloan Kettering Cancer Center
2007–2010
University of Oklahoma College of Medicine
2003–2007
University of Oklahoma
1999–2003

Research

The IASLC/ITMIG Thymic Epithelial Tumors Staging Project: proposal for an evidence-based stage classification system for the forthcoming (8th) edition of the TNM classification of…
Journal of Thoracic Oncology · 2014 · 365 citations
The IASLC/ITMIG Thymic Epithelial Tumors Staging Project: proposals for the T Component for the forthcoming (8th) edition of the TNM classification of malignant tumors
Journal of Thoracic Oncology · 2014 · 136 citations
Preoperative nutritional status is an important predictor of survival in patients undergoing surgery for renal cell carcinoma
European Urology · 2011 · 127 citations

Michael Cookson
19 papers
Sam Chang
8 papers
Joseph Smith
7 papers
KO
Kenneth Offit
7 papers
Peter Clark
7 papers
Todd Morgan
7 papers · 4 as a fellow
Daniel Barocas
6 papers
CM
Christopher Manschreck
5 papers
Duke Herrell
5 papers
KS
Kasmintan Schrader
5 papers
EM
Edith Marom
4 papers
FD
Frank Detterbeck
4 papers

Grants

NCI Research Specialist (Clinician Scientist) Award for Improving Cancer Screening and Clinical Trial Enrollment
National Cancer Institute · R50
Contact PI · $361.7K · University of Oklahoma Hlth Sciences Ctr
2025–2029

Clinical trials

Sipuleucel-T Based Autologous Cellular Immunotherapy for Advanced Prostate Cancer
Principal investigator · Active not recruiting · Phase 1
University of Oklahoma
2023–2028
Avelumab Plus Bacille Calmette-Guerin (BCG) in Patients With Non-muscle Invasive Bladder Cancer
Principal investigator · Completed · Phase 1, Phase 2
University of Oklahoma
2019–2023
Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial
Site PI · Recruiting · Phase 2
National Cancer Institute (NCI)
2025–2027
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study
Site PI · Recruiting · Phase 3
NRG Oncology
2025–2035